K191833

Substantially Equivalent

Dexcom G6 Pro Continuous Glucose Monitoring System

Applicant: Dexcom, Inc.
Product code: QII
Advisory panel: Clinical Chemistry
Date received: 2019-07-09
Decision date: 2019-10-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.